Matches in Nanopublications for { ?s ?p "[Prostate cancers respond to treatments that suppress androgen receptor (AR) function, with bicalutamide, flutamide, and cyproterone acetate (CPA) being AR antagonists in clinical use.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP650433.RAstikQvIptwftAjYzUIgV9t0TNhvB0nn8hPpFWkXaym4130_assertion description "[Prostate cancers respond to treatments that suppress androgen receptor (AR) function, with bicalutamide, flutamide, and cyproterone acetate (CPA) being AR antagonists in clinical use.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650433.RAstikQvIptwftAjYzUIgV9t0TNhvB0nn8hPpFWkXaym4130_provenance.